Deoxyadenosine-resistant mouse leukemia L1210 cell lines with alterations in early response genes and p53

Anticancer Research

Volumn 16, Issue 6 B, 1996, Pages 3483-3490

  Cory, Joseph G ^a   He, Ai Wu ^a   Cory, Ann H ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Early response genes; Mutant l1210 cells; p53

Indexed keywords

CISPLATIN; CYCLINE; CYCLOHEXIMIDE; DEOXYADENOSINE; MESSENGER RNA; PROTEIN P53;

ANIMAL CELL; ARTICLE; CELL CYCLE; CELL MUTANT; EARLY RESPONSE GENE; GENE AMPLIFICATION; LEUKEMIA CELL LINE; LEUKEMIA L 1210; MOUSE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C MYC; PRIORITY JOURNAL; TIME;

ANIMALS; CYCLOHEXIMIDE; DEOXYADENOSINES; DNA-BINDING PROTEINS; DRUG RESISTANCE, NEOPLASM; EARLY GROWTH RESPONSE PROTEIN 1; GENES, IMMEDIATE-EARLY; GENES, P53; IMMEDIATE-EARLY PROTEINS; LEUKEMIA L1210; MICE; PROTEIN SYNTHESIS INHIBITORS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; PROTO-ONCOGENE PROTEINS C-MYC; RNA, MESSENGER; TIME FACTORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0030499503     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Thompson DP, Carter GL, and Cory JG: Changes in messenger RNA levels for the subunits of ribonucleotide reductase during the cell cycle of leukemia L1210 cells. Cancer Commun 11: 253-260, 1989.
2. Dean M, Levine RA, Ran W, Kindy, Sonesnshein GE and Campisi J: Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact. J Bio Chem 261: 9161-9166, 1986.
3. Reich NC and Levine A: Growth regulation of a cellular tumor antigen. p53, in nontransformed cells. Nature 308: 199-201, 1984.
4. Carter GL and Cory JG: Cross-resistance patterns in hydroxyurea-resistant L1210 cells. Cancer Res 48: 5796-5799, 1988.
5. Carter GL and Cory JG: Selective resistance of L1210 cell lines to inhibitors directed at the subunits of ribonucleotide reductase. Adv. Enzyme Regul 29: 123-139, 1989.
6. Cory JG and Carter GL: Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors. Cancer Res 48: 839-843, 1988.
7. Cory JG, Cory AH, Long SD, Carter GL and Johnson CF: Altered steady-state levels of the messenger RNAs for c-myc and p53 in L1210 cell lines resistant to deoxyadenosine. Cancer Res: 52: 2000-2003, 1992.
8. Yin Y, Tainsky MA, Bischoff FZ, Strong LC and Wahl GM: Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant alleles. Cell 70: 937-948, 1992.
9. Livingstone LR, White A, Sprouse J, Livanos E, Jacks T and Tlsty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 Cell 70: 923-935, 1992.
10. Lowe SW, Ruley HE, Jacks T and Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993.
11. Cory AH, Owen TC, Barltrop JA and Cory JG: Use of an aqueous tetazolium/formazan assay for cell growth assays in culture. Cancer Commun 3: 207-212, 1991.
12. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem 162: 156-159, 1987.
13. Fourney RM, Mirjakoski J, Day RS III and Paterson MC: Northernblotting: efficient RNA strining and transfer. Focus 10: 5-6, 1988.
14. Band V, DeCaprio JA, Delmolino L, Karlesa V and Sager R: Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells. J Virology 65: 6671-6676, 1991.
15. Mercer WE, Shields MT, Lin D, Appella E and Ullrich S: Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression. Proc Natl Acad Sci USA 88: 1958-62, 1991.
16. Greenberg ME, Hermanowski AL and Ziff EB: Effect of protein synthesis inhibitors on growth factor activation of c-fos, c-myc and actin gene transcription. Mol Cell Biol 6: 1050-1057, 1986.
17. Edwards DR and Mahadevan LC: Protein synthesis inhibitors differentially superinduce c-fos and c-jun by three different distinct mechanisms: lack of evidence for labile repressors. EMBO 11: 2415-2424, 1992.
18. Voelkerding KV, Steffen DW, Zaidi SHE and Malter JS: Post-transcriptional regulation of the p53 tumor supressor gene during growth-induction of human peripheral blood mononuclear cells. Oncogene 10: 515-521, 1995.
19. Cox GS, Cosgrove DE, Sullivan TT and Haas MJ: Induction by cycloheximide of the glycoprotein hormone α-subunit gene in human tumor cell lines and identification of a possible negative regulatory factor. J Biol Chem 265: 13190-13197, 1990.